Physician profile
Christopher J Lyons
NPI 1093718017
$1,448.44
in general payments reported to CMS, 2019-2025
20 companies · $284 in 2025
The $284 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $381 · 2020: $115 · 2021: $122 · 2022: $84.60 · 2023: $281 · 2024: $180 · 2025: $284.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $746.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $746.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $217.62 | 2023-2025 | Axsos, Pangea, Gamma |
| Pacira Therapeutics, INC. | $189.93 | 2019-2021 | |
| Smith+Nephew, INC. | $115.73 | 2019-2021 | |
| Dynasplint Systems INC. | $111.72 | 2019-2023 | Dynasplint |
| Zimmer Biomet Holdings, INC. | $104.41 | 2024-2025 | Gel-One Cross-Linked Hyaluronate |
| Amniox Medical, INC. | $96.63 | 2019 | |
| Eclipse Technology Solutions INC. | $82.66 | 2022-2023 | |
| Depuy Synthes Sales INC. | $81.89 | 2019-2025 | Monovisc, Orthovisc |
| Endo Pharmaceuticals INC. | $71.25 | 2019-2022 | |
| Ferring Pharmaceuticals INC. | $62.58 | 2023-2025 | Rebyota, Euflexxa |
| Vertex Pharmaceuticals Incorporated | $52.02 | 2024-2025 | |
| Solventum Corporation | $38.76 | 2024-2025 | Prevena |
| Bioventus LLC | $36.66 | 2023 | Exogen Ultrasound Bone Healing System |
| Heraeus Medical, LLC. | $36.01 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $33.07 | 2023 | Iovera, Exparel, Zilretta |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $32.55 | 2023 | V.A.C. Dermatac, Activ.A.C. |
| Mallinckrodt Enterprises LLC | $28.86 | 2019 | |
| Integra Lifesciences Corporation | $22.55 | 2020 | |
| Davol INC. | $20.41 | 2025 | Arista |
| Axogen | $13.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Lyons listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.